Enteral Nutrition Market Overview, Size, Trends And Forecast 2020-2027
Enteral Nutrition Market |
Any feeding technique
that involves ingesting food through the digestive tract to meet a person's
caloric needs is referred to as enteral nutrition. The increase in the elderly
population and the number of cases of malnutrition are two additional reasons
driving the Enteral Nutrition Market
expansion. A regular diet, the use of liquid or powdered supplements, and tube
feeding are also possible. The patient can get enteral nutrition using a
variety of tools and equipment.
These include pipes,
pumps, and other devices that facilitate the simple passage of liquids into the
gastrointestinal tract. For those with diabetes, malnutrition, cancer,
gastrointestinal issues, and other complications, enteral nutrition is
necessary. Patients with nutritional deficiencies can also get enteral feeding.
The
Enteral
Nutrition Market Is Anticipated To Reach An Estimated Value Of Us$ 2,635.9
Million In 2020 And Grow At A CAGR Of 5.8% From 2020 To 2027.
Additionally, enteral
nutrition is becoming increasingly popular due to improvements in procedures
and the addition of appropriate components to the product composition. However,
it is projected that lower demand from undeveloped nations will restrain Enteral Nutrition Market expansion. On
the other hand, underdeveloped emerging economies with significant market
potential are predicted to offer profitable chances for market expansion.
Competitive
Landscape
Major players
participanting in the global Enteral
Nutrition Market include Abbott Laboratories, Nestlé S.A., Danone S.A.,
Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG,
Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma,
Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis
Health Caps SP.
Enteral
Nutrition Market Trends
Growing
Aging Population: The world's population has been aging,
particularly in developed countries. With an increasing elderly population, the
demand for enteral nutrition products has risen as these individuals often face
difficulties in consuming regular solid food due to various health issues.
Prevalence
of Chronic Diseases: The rising incidence of chronic
diseases such as cancer, neurological disorders, and gastrointestinal disorders
has led to an increased need for Enteral
Nutrition Market. Patients with conditions that affect their ability to eat
normally may require tube feeding or oral supplements to meet their nutritional
needs.
Anticonvulsant
Drugs are medicinal agents employed in the management of
epileptic disorders, serving as a valuable adjunct to seizure control by either
increasing the threshold for seizures or decreasing their severity and
frequency.
Technological
Advancements: The Enteral Nutrition Market has witnessed technological advancements
in feeding tube design, pump systems, and formulations. These innovations have
made enteral feeding more efficient, comfortable, and safer for patients.
Home
Enteral Nutrition: More patients are now receiving
enteral nutrition at home rather than in hospitals or healthcare facilities.
This trend has been supported by the development of user-friendly enteral
feeding systems and better caregiver training.
Comments
Post a Comment